Colossal Biosciences

About:

Colossal is a bioscience and genetic engineering company that focuses on de-extinction of past species.

Website: https://colossal.com

Twitter/X: ItIsColossal

Top Investors: Animoca Brands, Sahin Boydas, Draper Associates, In-Q-Tel, Capital Factory

Description:

Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through innovative science and technology.

Total Funding Amount:

$248M

Headquarters Location:

Dallas, Texas, United States

Founded Date:

2021-02-04

Contact Email:

info(AT)colossal.com

Hub Tags:

Unicorn

Founders:

Ben Lamm, Kent Wakeford, Peter Phillips

Number of Employees:

101-250

Last Funding Date:

2023-11-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai